ClinicalTrials.gg

Program

ciprofol

Also written as “HSK3486”, “Ciprofol” and “Cipepofol”.

Its studies are mostly in Arrhythmias, Cardiac · Renal Insufficiency, Chronic, led by Haisco Pharmaceutical Group.

Furthest: phase 4, since Aug 27, 202136 company-led studies, 2 open or runningNext primary completion: May 2028 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Haisco Pharmaceutical Group362 open or runningphase 4since Aug 27, 2021Sep 11, 2018May 2028phase 3 · NCT07510945

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 22 studies since Sep 11, 2018.

  1. Aug 11, 2020Phase 3 study in Induction and Maintenance of General AnesthesiaNCT04511728 · 129 enrolled · China
  2. Oct 21, 2020Phase 3 study in Sedation in Intensive CareNCT04620031 · 135 enrolled · China
  3. Nov 30, 2020Phase 2 study in Sedation in Intensive CareNCT04669821 · 20 enrolled · China
  4. Jan 12, 2021Phase 3 study in AnesthesiaNCT04711837 · 255 enrolled · United States
  5. Jun 23, 2021Phase 3 study in Gynecological Outpatient SurgeryNCT04958746 · 135 enrolled · China
  6. Aug 27, 2021Phase 4 study in Anesthesia, GeneralNCT05035069 · 24 enrolled · China
  7. Jul 22, 2022Phase 3 study in General AnesthesiaNCT05478174 · 400 enrolled · United States
  8. Aug 1, 2022Phase 3 study in General AnesthesiaNCT05486416 · 465 enrolled · United States, Poland, Spain
  9. Oct 12, 2022Phase 1 study in General AnesthesiaNCT05614544 · 42 enrolled · United States
  10. Apr 25, 2024Phase 3 study in AnesthesiaNCT06391931 · 190 enrolled · China
  11. Dec 13, 2024Phase 4 study in AnesthesiaNCT06740201 · 40 planned · China
  12. Jan 22, 2025Phase 1 study in Arrhythmias, CardiacNCT06795204 · 48 enrolled · China
  13. Feb 4, 2026Phase 1 study in General AnesthesiaNCT07404306 · 43 enrolled · United States
  14. Mar 29, 2026Phase 3 study in General AnestheticNCT07510945 · 400 planned

Ahead

  1. May 2028Primary completion: phase 3 study in General AnestheticNCT07510945

TargetBeta

“GABA-A receptor; anion channel agonist”ChEMBL 37, by rule

Other programs on the same 16 targets

ProgramCompanyFurthest phaseStudies
MidazolamrulePfizerphase 496
AlprazolamruleViatrisphase 435
brexanoloneruleSupernus Pharmaceuticalsphase 414
DiazepamruleAcorda Therapeuticsphase 39

Studies

All 36 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07510945General Anesthetic3Not yet recruitingMay 2028400
NCT07404306General Anesthesia · United States1CompletedOct 3, 202343
NCT06795204Arrhythmias, Cardiac · China1CompletedMay 19, 202448
NCT06740201Anesthesia · China4RecruitingMar 30, 202540
NCT06391931Anesthesia · China3CompletedNov 6, 2024190
NCT05614544General Anesthesia · United States1CompletedOct 3, 202342
NCT05486416General Anesthesia · United States, Poland, Spain3CompletedJul 23, 2024465
NCT05478174General Anesthesia · United States3CompletedNov 7, 2023400
NCT05035069Anesthesia, General · China4UNKNOWNFeb 3, 202224
NCT04958746Gynecological Outpatient Surgery · China3CompletedSep 29, 2021135
NCT04711837Anesthesia · United States3CompletedApr 13, 2022255
NCT04669821Sedation in Intensive Care · China2CompletedAug 28, 202120
NCT04620031Sedation in Intensive Care · China3CompletedJun 2, 2021135
NCT04511728Induction and Maintenance of General Anesthesia · China3CompletedDec 31, 2020129
NCT04294056Anesthesia · China1CompletedJun 22, 202018
NCT04197661Healthy Elderly Subjects · China1CompletedJan 22, 202032
NCT04147416Sedation · China2CompletedMay 31, 202039
NCT04145583Anesthesia · China1CompletedJan 6, 202016
NCT04142970Renal Insufficiency, Chronic · China1CompletedAug 4, 202024
NCT04145596Hepatic Impairment · China1CompletedApr 20, 202024
NCT04111159Sedation or Anesthesia · China3CompletedJun 19, 2020267
NCT04048811Induction and Maintenance of General Anesthesia · China2CompletedMay 23, 202046
NCT04037657Anesthesia1CompletedJun 9, 201525
NCT04054063General Anesthetic1CompletedDec 21, 201625
NCT04033939Anesthesia1CompletedNov 11, 201448
NCT04029766Anesthesia1CompletedDec 14, 201513
NCT03808844Induction of Anesthesia · China3CompletedAug 14, 2019178
NCT03773835Anesthesia1CompletedAug 201624
NCT03773042Colonoscopy · China2CompletedJun 201764
NCT03758469Anesthesia · China1CompletedJan 31, 201916
NCT03751969Anesthesia1WithdrawnNov 1, 20200
NCT03751956Anesthesia · China1CompletedFeb 28, 20196
NCT03745625Anesthesia · China1CompletedJul 2, 201916
NCT03709056Sedation and Anesthesia for Adult Colonoscopy Procedures · China2CompletedFeb 2, 201894
NCT03698617Induction of General Anaesthesia · China2CompletedJun 29, 2018114
NCT03674008Sedation or Anesthesia · China3CompletedJan 9, 2019280

How it is read

Names in the registry

  • “HSK3486”, 32 entries
  • “Ciprofol”, 3 entries
  • “Cipepofol”, 2 entries
  • “HSK3486 0.1-0.2 /0.3 mg / kg group”, 1 entry
  • “voriconazole +HSK3486”, 1 entry

Codes read as this program: HSK3486.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.